Biovitrum AB (publ) (”Biovitrum”) has today completed the previously announced acquisition of Swedish Orphan International Holding AB (“Swedish Orphan”). Biovitrum has acquired all shares and warrants in Swedish Orphan by payment of a consideration consiting of approximately SEK 1,923 million in cash and in addition newly issued common shares in Biovitrum.

Download the whole press release here.